CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 8, 2020—Nova Biomedical has added PT/INR testing to its Allegro capillary blood analyzer for point-of-care testing in primary care settings. The upgrade allows Allegro to monitor patient coagulation therapy in addition to testing for glycemic control, kidney function, anemia, gout, and cardiac risk with a full lipids panel. PT/INR is one of 18 tests for the Allegro and its StatStrip-A companion meter, including HbA1c, cholesterol, triglycerides, glucose, creatinine, uACR, hemoglobin, hematocrit, and uric acid.
Allegro is a compact POC analyzer that features a menu of 12 measured and individually selectable tests plus six calculated tests. Tests use capillary fingerstick sampling and disposable test cartridges or strips. Its design comprises dual measurement bays, which offers the ability to measure two cartridges simultaneously. Cartridge test times are six to nine minutes.